Figure 1.
Cohort construction from The 90+ Study participants. Of the total 1921 participants, 496 were seen between 2014 (when the neuroimaging component of the study began) and 2018. Between 2014–2018, 258 participants gave informed consent to participate in the neuroimaging study. Cystatin C level was determined for 193 and brain MRI was completed in 129 participants.